INR 1678.7
(-1.96%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.07 Billion INR | -2.05% |
2022 | 2.12 Billion INR | 8.81% |
2021 | 1.95 Billion INR | 27.02% |
2020 | 1.53 Billion INR | 38.1% |
2019 | 1.11 Billion INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q4 | 2.07 Billion INR | 0.0% |
2023 FY | 2.07 Billion INR | -2.05% |
2023 Q2 | 2.19 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q3 | - INR | -100.0% |
2022 Q4 | 2.12 Billion INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Biocon Limited | 49.43 Billion INR | 95.794% |
Blue Jet Healthcare Limited | 1.29 Billion INR | -60.168% |
Dishman Carbogen Amcis Limited | 8.82 Billion INR | 76.446% |
Jubilant Ingrevia Limited | 9.41 Billion INR | 77.908% |
Lyka Labs Limited | 95.71 Million INR | -2072.567% |
Panacea Biotec Limited | 1.77 Billion INR | -16.867% |
Piramal Pharma Limited | 21.75 Billion INR | 90.443% |
SMS Lifesciences India Limited | 812.1 Million INR | -156.068% |
Supriya Lifescience Limited | 852.49 Million INR | -143.937% |
Syngene International Limited | 2.38 Billion INR | 12.808% |
TAKE Solutions Limited | 7.96 Million INR | -26024.849% |
Zota Health Care Limited | 537.66 Million INR | -286.775% |